Device Trial Radar · NCT01368666
Safety and Effectiveness Study of Perceval S Valve for Extended CE Mark
Last checked: Nov 19, 2026Latest source record: Mar 6, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
658
Actual
Start
Feb 23, 2010
Primary completion
Oct 31, 2014
Study completion Jan 31, 2020
Sponsor
- Lead sponsor
- Corcym S.r.lNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jun 8, 2011
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this clinical investigation is to assess the safety and effectiveness of the Perceval S valve at 12 months after implantation when used to replace a diseased or dysfunctional aortic valve or aortic valve prosthesis.
Conditions
- Aortic Valve Replacement
Interventions
Perceval S Valve ProsthesisDevice
Replacement of diseased or malfunctioning native aortic valve with the Perceval S valve prosthesis
Primary outcomes
What the sponsor says the trial is designed to measure.
- Evaluation of the safety: incidence of mortalityTime frame: 12 months after OP
- Evaluation of the safety: Incidence of morbidityTime frame: 12 months after OP
- Evaluation of NYHA functional classTime frame: 12 months after OP
5 more outcomes with a free account
Locations
26 sites in 8 countries. Site status is shown where the registry gives one.
Universitäts-Klinik für Chirurgie
Graz, Austria
Universitätsklinik für Chirurgie
Vienna, Austria
Onze-Lieve-Vrouw (OLV) Ziekenhuis
Aalst, Belgium
23 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.